FOXC1 and colorectal carcinoma: Furthermore, a novel protein (circMAPK14‐175aa), encoded by circMAPK14, exhibited tumour‐suppressive effects and competed with upstream kinase MKK6 to facilitate ubiquitin‐mediated degradation of FOXC1 and block CRC development.